Holger J. Schünemann

202.6k total citations · 51 hit papers
712 papers, 87.8k citations indexed

About

Holger J. Schünemann is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Holger J. Schünemann has authored 712 papers receiving a total of 87.8k indexed citations (citations by other indexed papers that have themselves been cited), including 279 papers in Economics and Econometrics, 255 papers in Public Health, Environmental and Occupational Health and 210 papers in General Health Professions. Recurrent topics in Holger J. Schünemann's work include Health Systems, Economic Evaluations, Quality of Life (269 papers), Clinical practice guidelines implementation (206 papers) and Meta-analysis and systematic reviews (175 papers). Holger J. Schünemann is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (269 papers), Clinical practice guidelines implementation (206 papers) and Meta-analysis and systematic reviews (175 papers). Holger J. Schünemann collaborates with scholars based in Canada, United States and Italy. Holger J. Schünemann's co-authors include Gordon Guyatt, Andrew D Oxman, Gunn Elisabeth Vist, Regina Kunz, Yngve Falck–Ytter, Pablo Alonso‐Coello, Jan Brożek, Elie A. Akl, Joerg J Meerpohl and Susan L. Norris and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Holger J. Schünemann

691 papers receiving 85.4k citations

Hit Papers

GRADE: an emerging consensus on rating quality of evidenc... 2004 2026 2011 2018 2008 2011 2008 2010 2011 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
    2008 14.7k citations Gordon Guyatt, Andrew D Oxman et al. BMJ profile →
  2. GRADE guidelines: 3. Rating the quality of evidence
    2011 5.8k citations Holger J. Schünemann, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  3. What is “quality of evidence” and why is it important to clinicians?
    2008 2.3k citations Gordon Guyatt, Andrew D Oxman et al. BMJ profile →
  4. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
    2010 2.1k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  5. GRADE guidelines 6. Rating the quality of evidence—imprecision
    2011 1.9k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  6. GRADE guidelines: 7. Rating the quality of evidence—inconsistency
    2011 1.7k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  7. GRADE guidelines: 5. Rating the quality of evidence—publication bias
    2011 1.4k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  8. GRADE guidelines: 8. Rating the quality of evidence—indirectness
    2011 1.4k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  9. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
    2014 1.3k citations Holger J. Schünemann, M. Hassan Murad et al. BMJ profile →
  10. GRADE guidelines: 2. Framing the question and deciding on important outcomes
    2010 1.3k citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  11. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
    2010 1.3k citations Jan Brożek, Carlos E. Baena‐Cagnani et al. Journal of Allergy and Clinical Immunology profile →
  12. Going from evidence to recommendations
    2008 1.2k citations Gordon Guyatt, Andrew D Oxman et al. BMJ profile →
  13. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
    2008 1.1k citations Holger J. Schünemann, Andrew D Oxman et al. profile →
  14. GRADE guidelines: 9. Rating up the quality of evidence
    2011 971 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  15. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies
    2015 940 citations Holger J. Schünemann et al. BMJ profile →
  16. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
    2013 883 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  17. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group
    2004 869 citations Gordon Guyatt, Andrew D Oxman et al. profile →
  18. Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
    2006 862 citations Gordon Guyatt, Holger J. Schünemann et al. profile →
  19. GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
    2013 832 citations Holger J. Schünemann, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  20. Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes
    2018 804 citations Holger J. Schünemann et al. profile →
  21. Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
    2011 771 citations Holger J. Schünemann et al. profile →
  22. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
    2016 771 citations Holger J. Schünemann, Romina Brignardello‐Petersen et al. BMJ profile →
  23. Chapter 12: Interpreting results and drawing conclusions
    2011 730 citations Holger J. Schünemann, Andrew D Oxman et al. profile →
  24. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
    2019 686 citations Nancy Santesso, Elie A. Akl et al. Journal of Clinical Epidemiology profile →
  25. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients
    2015 597 citations Paul Glasziou, Holger J. Schünemann et al. BMJ profile →
  26. Grading quality of evidence and strength of recommendations in clinical practice guidelines
    2009 584 citations Jan Brożek, Elie A. Akl et al. profile →
  27. GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
    2018 564 citations Holger J. Schünemann, Elie A. Akl et al. Journal of Clinical Epidemiology profile →
  28. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
    2012 563 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  29. GRADE guidelines: 12. Preparing Summary of Findings tables—binary outcomes
    2012 555 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  30. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
    2017 517 citations Romina Brignardello‐Petersen, Paul Alexander et al. Journal of Clinical Epidemiology profile →
  31. GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
    2012 502 citations Gordon Guyatt, Andrew D Oxman et al. Journal of Clinical Epidemiology profile →
  32. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
    2009 496 citations Giorgio Walter Canonica, Holger J. Schünemann et al. profile →
  33. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines
    2016 495 citations Andrew D Oxman, Romina Brignardello‐Petersen et al. BMJ profile →
  34. The GRADE Working Group clarifies the construct of certainty of evidence
    2017 468 citations Monica Hultcrantz, David M. Rind et al. Journal of Clinical Epidemiology profile →
  35. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
    2018 467 citations Holger J. Schünemann, Mary Cushman et al. Blood Advances profile →
  36. Diagnosis of DVT
    2012 455 citations Roman Jaeschke, Holger J. Schünemann et al. profile →
  37. Rating the certainty in evidence in the absence of a single estimate of effect
    2017 448 citations M. Hassan Murad, Reem A. Mustafa et al. profile →
  38. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis
    2018 426 citations Derek K. Chu, Roman Jaeschke et al. profile →
  39. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
    2012 390 citations Holger J. Schünemann et al. profile →
  40. Cytology versus HPV testing for cervical cancer screening in the general population
    2017 341 citations Nancy Santesso, Reem A. Mustafa et al. profile →
  41. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
    2019 282 citations Derek K. Chu, Alessandro Fiocchi et al. profile →
  42. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
    2014 278 citations Elie A. Akl, Ignacio Neumann et al. profile →
  43. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks
    2020 252 citations Gordon Guyatt, Reem A. Mustafa et al. Journal of Clinical Epidemiology profile →
  44. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism
    2018 239 citations Wojtek Wiercioch, Holger J. Schünemann et al. Blood Advances profile →
  45. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions
    2018 207 citations Andrew D Oxman, Holger J. Schünemann et al. profile →
  46. GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework
    2020 202 citations Romina Brignardello‐Petersen, Iván D. Flórez et al. BMJ profile →
  47. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings
    2021 167 citations Romina Brignardello‐Petersen, Monica Hultcrantz et al. Journal of Clinical Epidemiology profile →
  48. GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach
    2022 137 citations Romina Brignardello‐Petersen, Monica Hultcrantz et al. Journal of Clinical Epidemiology profile →
  49. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing
    2023 92 citations Robby Nieuwlaat, Yuan Zhang et al. Blood Advances profile →
  50. The development methods of official GRADE articles and requirements for claiming the use of GRADE – A statement by the GRADE guidance group
    2023 86 citations Holger J. Schünemann, Elie A. Akl et al. Journal of Clinical Epidemiology profile →
  51. GRADE guidance 36: updates to GRADE's approach to addressing inconsistency
    2023 73 citations Reem A. Mustafa, Ariel Izcovich et al. Journal of Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger J. Schünemann Canada 118 15.6k 15.5k 11.5k 11.2k 10.4k 712 87.8k
Andrew D Oxman Norway 93 18.6k 1.2× 18.1k 1.2× 11.7k 1.0× 12.3k 1.1× 19.4k 1.9× 300 107.1k
Kenneth F. Schulz United States 79 17.3k 1.1× 16.6k 1.1× 8.9k 0.8× 10.3k 0.9× 11.1k 1.1× 216 102.7k
Erik von Elm Switzerland 43 18.6k 1.2× 12.9k 0.8× 10.4k 0.9× 13.1k 1.2× 10.1k 1.0× 131 89.7k
Paul Glasziou Australia 110 10.5k 0.7× 11.2k 0.7× 7.6k 0.7× 8.2k 0.7× 12.2k 1.2× 647 68.0k
P.J. Devereaux Canada 84 24.8k 1.6× 10.6k 0.7× 11.4k 1.0× 10.0k 0.9× 7.8k 0.7× 404 96.0k
Jonathan A C Sterne United Kingdom 97 13.3k 0.9× 9.2k 0.6× 8.7k 0.8× 12.0k 1.1× 6.2k 0.6× 402 84.3k
Jos Kleijnen United Kingdom 82 17.2k 1.1× 10.0k 0.6× 10.5k 0.9× 10.6k 1.0× 7.3k 0.7× 324 90.0k
Víctor M. Montori United States 123 13.3k 0.9× 12.2k 0.8× 5.1k 0.4× 9.5k 0.9× 14.1k 1.4× 695 77.1k
Cynthia D. Mulrow United States 60 17.6k 1.1× 10.0k 0.6× 9.9k 0.9× 9.9k 0.9× 8.3k 0.8× 142 90.2k
Jan P. Vandenbroucke Netherlands 93 21.8k 1.4× 14.5k 0.9× 12.6k 1.1× 15.5k 1.4× 10.2k 1.0× 439 111.3k

Countries citing papers authored by Holger J. Schünemann

Since Specialization
Citations

This map shows the geographic impact of Holger J. Schünemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger J. Schünemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger J. Schünemann more than expected).

Fields of papers citing papers by Holger J. Schünemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger J. Schünemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger J. Schünemann. The network helps show where Holger J. Schünemann may publish in the future.

Co-authorship network of co-authors of Holger J. Schünemann

This figure shows the co-authorship network connecting the top 25 collaborators of Holger J. Schünemann. A scholar is included among the top collaborators of Holger J. Schünemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger J. Schünemann. Holger J. Schünemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hao, Qiukui, Ya Gao, M. Hassan Murad, et al.. (2023). GRADE concept 6: a novel application of external indirect evidence into GRADE ratings of evidence certainty in network meta-analysis. Journal of Clinical Epidemiology. 163. 95–101. 3 indexed citations
3.
Piggott, Thomas, Artur Nowak, Romina Brignardello‐Petersen, et al.. (2022). Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO. BMJ Open. 12(2). e053349–e053349. 17 indexed citations
4.
Neumann, Ignacio, et al.. (2022). Using Explicit Thresholds were valuable for judging Benefits and Harms in partially contextualized GRADE Guidelines. Journal of Clinical Epidemiology. 147. 69–75. 12 indexed citations
5.
Brignardello‐Petersen, Romina, Gordon Guyatt, Reem A. Mustafa, et al.. (2021). GRADE guidelines 33: Addressing imprecision in a network meta-analysis. Journal of Clinical Epidemiology. 139. 49–56. 49 indexed citations
6.
Brignardello‐Petersen, Romina, Ariel Izcovich, Bram Rochwerg, et al.. (2020). GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework. BMJ. 371. m3907–m3907. 92 indexed citations
7.
Schünemann, Holger J., Elie A. Akl, Roger Chou, et al.. (2020). Use of facemasks during the COVID-19 pandemic. The Lancet Respiratory Medicine. 8(10). 954–955. 59 indexed citations
8.
Piran, Siavash, Rasha Khatib, Sam Schulman, et al.. (2019). Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Advances. 3(2). 158–167. 84 indexed citations
9.
Schünemann, Holger J., Mary Cushman, Allison Burnett, et al.. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Advances. 2(22). 3198–3225. 467 indexed citations breakdown →
10.
11.
Ferguson, Niall D., Damon C. Scales, Ruxandra Pinto, et al.. (2012). Integrating Mortality and Morbidity Outcomes. American Journal of Respiratory and Critical Care Medicine. 187(3). 256–261. 35 indexed citations
12.
Brożek, Jan, Luigi Terracciano, Jonathan C. Hsu, et al.. (2011). Oral immunotherapy for IgE ‐mediated cow's milk allergy: a systematic review and meta‐analysis. Clinical & Experimental Allergy. 42(3). 363–374. 132 indexed citations
13.
Wilson, Kevin C. & Holger J. Schünemann. (2011). An Appraisal of the Evidence Underlying Performance Measures for Community-acquired Pneumonia. American Journal of Respiratory and Critical Care Medicine. 183(11). 1454–1462. 27 indexed citations
14.
Fiocchi, Alessandro, Holger J. Schünemann, Jan Brożek, et al.. (2010). Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA): A summary report. Journal of Allergy and Clinical Immunology. 126(6). 1119–1128.e12. 200 indexed citations
15.
Schünemann, Holger J., Andrew D Oxman, Jan Brożek, et al.. (2009). Grading Quality of Evidence and Strength of Recommendations for Diagnostic Tests and Strategies. Zhongguo xunzheng yixue zazhi. 9(5). 503–508. 13 indexed citations
16.
Schünemann, Holger J., Molly L. Osborne, Joel Moss, et al.. (2009). An Official American Thoracic Society Policy Statement: Managing Conflict of Interest in Professional Societies. American Journal of Respiratory and Critical Care Medicine. 180(6). 564–580. 78 indexed citations
17.
Jaeschke, Roman, Paul M. O’Byrne, Filip Mejza, et al.. (2008). The Safety of Long-Acting β-Agonists among Patients with Asthma Using Inhaled Corticosteroids. American Journal of Respiratory and Critical Care Medicine. 178(10). 1009–1016. 74 indexed citations
18.
Schünemann, Holger J., Roman Jaeschke, Richard J. Cook, et al.. (2006). An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations. American Journal of Respiratory and Critical Care Medicine. 174(5). 605–614. 411 indexed citations
19.
Ochs‐Balcom, Heather M., Brydon J. B. Grant, Paola Muti, et al.. (2005). Oxidative Stress and Pulmonary Function in the General Population. American Journal of Epidemiology. 162(12). 1137–1145. 37 indexed citations
20.
Schünemann, Holger J., Brydon J. B. Grant, Jo L. Freudenheim, et al.. (2001). The Relation of Serum Levels of Antioxidant Vitamins C and E, Retinol and Carotenoids with Pulmonary Function in the General Population. American Journal of Respiratory and Critical Care Medicine. 163(5). 1246–1255. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew D Oxman Breakdown of academic impact, for papers by Kenneth F. Schulz Breakdown of academic impact, for papers by Erik von Elm Breakdown of academic impact, for papers by Paul Glasziou Breakdown of academic impact, for papers by P.J. Devereaux Breakdown of academic impact, for papers by Jonathan A C Sterne Breakdown of academic impact, for papers by Jos Kleijnen Breakdown of academic impact, for papers by Víctor M. Montori Breakdown of academic impact, for papers by Cynthia D. Mulrow Breakdown of academic impact, for papers by Jan P. Vandenbroucke
Rankless by CCL
2026